Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -17.2% | -3.5% | 1 / 3 | -25.2% | +0.14 pp | +0.01 pp | +0.1% | 1.23 | 115.41 | 128 | −25,2% | 0,1 | −17,2% | 115.41 | 123.55 | −6,6% |
| Pts | 0 | 0 | 4 | 0 | 8 | 8 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 1.700 (close price on 2026-10-20)EPS (TTM): 14,7
Financial charts
1.Revenue & growth
VND bn128Q2/26
1.Revenue & growth
VND bn128Q2/26
2.Profit & growth
VND bn0,08Q2/26
3.Profit mix (Penman)
VND bn0,25Q2/26
4.Margins & cost structure
%0.1%Q2/26
5.Returns & cash cycle
% · days-0.1%Q2/26
6.Earnings quality & cash
VND bn-2,86Q2/26
7.Asset structure
VND bn351Q2/26
8.Funding & debt health
VND bn · times351Q2/26
9.Revenue backlog
VND bn0,21Q2/26
10.Valuation
times · %115,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %6Q2/26
Adjusted EPS growth, latest quarter
-17.2%
Average adjusted EPS growth, 3 quarters
-3.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26